+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Glycoprotein Ib alpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques



Glycoprotein Ib alpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques



Thrombosis and Haemostasis 97(3): 435-443



Anti-platelet drugs are used to prevent intra-arterial thrombus formation after rupture of atherosclerotic plaques. Until now, the inhibitory effect of present and future anti-platelet drugs such as aspirin,ADP receptor P2Y(1)/P2Y(12) antagonists and glycoprotein (GP) Ib alpha inhibitors on the interaction of platelets with human plaques is not known. To study those effects we obtained human atherosclerotic plaques by surgical endarterectomy. Plaques induced maximal platelet aggregation in hirudinized platelet-rich plasma (PRP) and blood that was effectively inhibited by aspirin,the P2Y(1) antagonist MRS2179 and the P2Y(12) antagonist AR-C69931MX, but not by GPIb alpha blockade with the mAB 6B4. Inhibition of platelet aggregation by MRS2179 was 74 +/- 37% and 68 +/- 20%, by AR-C69931MX 94 +/- 7% and 80 +/- 6%, and by aspirin 88 +/- 19% and 64 +/- 28%, in PRP and blood, respectively (mean +/- SD; n=6-12 with plaques from 6 patients).The combination of both ADP receptor antagonists completely inhibited plaque-induced platelet aggregation in hirudinized PRP and blood. Under arterial flow conditions (1,500s(-1)), blockade of platelet GPIb alpha resulted in a strong decrease of plaque-stimulated platelet adhesion/aggregate formation of 77 +/- 5% (mean +/- SD; n=4). Furthermore, MRS2179, AR-C69931MX and their combination reduced plaque-dependent platelet aggregate formation by 35 +/- 14%,32 13% and 58 +/- 12% (mean +/- SD; n=5), respectively. Aspirin was without significant effect. In conclusion,a GPIb alpha-blocking antibodyas well as P2Y(1) and P2Y(12) receptor antagonists, alone or in combination, reduce in contrast to aspirin human plaque-induced platelet thrombus formation under arterial flow. Although these new anti-platelet agents inhibit platelet thrombus formation after plaque rupture, more efficient platelet blockers are required.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 013247215

Download citation: RISBibTeXText

PMID: 17334511


Related references

Platelet adhesion and platelet thrombus formation on subendothelium of human arteries and veins exposed to flowing blood in vitro. A comparison with rabbit aorta. Haemostasis 8(1): 19-29, 1979

Dimers of beta2-glycoprotein I induce increased platelet adhesion and thrombus formation in flowing blood. Lupus 11(9): 553, 2002

Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arteriosclerosis Thrombosis and Vascular Biology 22(4): 686-691, 2002

Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood. Journal of Clinical Investigation 94(3): 1098-1112, 1994

Platelet adherence and thrombus formation with flowing human blood on atherosclerotic plaque: reduced thrombogenicity of Watanabe-heritable hyperlipidemic rabbit aortic subendothelium. Thrombosis Research 54(2): 99, 1989

Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 103(4): 1333-1341, 2004

Thrombus inhibition to reduce restenosis after angioplasty using monoclonal antibodies against tissue factor and the platelet GPIIb/IIIa receptor in an atherosclerotic rabbit. Clinical Research 42(2): 184A, 1994

Axial dependence of collagen-induced thrombus formation in flowing non-anticoagulated human blood. Anti-platelet drugs impair thrombus growth and increase platelet-collagen adhesion. Thrombosis and Haemostasis 73(1): 126-131, 1995

Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency. Blood 63(5): 1004-1014, 1984

Role of 5-hydroxytryptamine in platelet thrombus formation and mechanisms of inhibition of thrombus formation by 5-hydroxytryptamine2A antagonists in rabbits. Archives Internationales de Pharmacodynamie et de Therapie 330(3): 297-308, 1995

Effect of 5-HT2A receptor antagonists on human platelet activation in blood exposed to physiologic stimuli and atherosclerotic plaque. Journal of Thrombosis and Haemostasis 9(10): 2112-2115, 2011

Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. Faseb Journal 19(8): 898-909, 2005

Inhibition of epinephrine induced platelet thrombus formation by caffeine and aspirin but not with dipyridamole and aspirin in stenosed dog coronary arteries. Clinical Research 36(3): 275A, 1988

Procoagulant human monocytes mediate tissue factor/factor VIIa-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood. Arteriosclerosis Thrombosis and Vascular Biology 15(1): 11-16, 1995